Expression Table for this CRE
| CNhs14417 | 293SLAM rinderpest infection, 24hr, biol_rep2 | 14.0 |
| CNhs14429 | COBL-a rinderpest infection, 24hr, biol_rep2 | 2.8 |
| CNhs11986 | Smooth Muscle Cells - Carotid, donor2 | 1.6 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 1.0 |
| CNhs13725 | HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 1.0 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 0.9 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 0.9 |
| CNhs11934 | myelodysplastic syndrome cell line:SKM-1 | 0.7 |
| CNhs13435 | achilles tendon, donor2 | 0.7 |
| CNhs12829 | H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9) | 0.7 |
| CNhs13377 | Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56) | 0.6 |
| CNhs11982 | Preadipocyte - visceral, donor2 | 0.6 |
| CNhs12101 | Mesenchymal Stem Cells - adipose, donor2 | 0.5 |
| CNhs12896 | H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 0.5 |
| CNhs12498 | Fibroblast - Cardiac, donor1 | 0.5 |
| CNhs11844 | acantholytic squamous carcinoma cell line:HCC1806 | 0.4 |
| CNhs14059 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 0.4 |
| CNhs12465 | K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1 | 0.4 |
| CNhs12464 | K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1 | 0.4 |
| CNhs13501 | Hep-2 cells mock treated, biol_rep3 | 0.4 |
| CNhs13361 | Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 0.4 |
| CNhs13410 | Adipocyte differentiation, day04, donor2 | 0.4 |
| CNhs14487 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 0.4 |
| CNhs14604 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 0.4 |
| CNhs13353 | Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43) | 0.4 |
| CNhs13437 | cerebrospinal fluid, donor2 | 0.4 |
| CNhs11769 | thyroid, fetal, donor1 | 0.3 |
| CNhs14613 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 0.3 |
| CNhs12017 | Adipocyte - subcutaneous, donor3 | 0.3 |
| CNhs12344 | Fibroblast - Choroid Plexus, donor2 | 0.3 |
| CNhs13548 | CD14-CD16+ Monocytes, donor3 | 0.3 |
| CNhs13360 | Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8) | 0.3 |
| CNhs12229 | pituitary gland, adult, donor10252 | 0.3 |
| CNhs12117 | Astrocyte - cerebellum, donor3 | 0.3 |
| CNhs14542 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 0.3 |
| CNhs13367 | Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 0.2 |
| CNhs12397 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16) | 0.2 |
| CNhs12795 | K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3 | 0.2 |
| CNhs12925 | Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 0.2 |
| CNhs13736 | HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3 | 0.2 |
| CNhs13112 | Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14) | 0.2 |
| CNhs12405 | Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 0.2 |
| CNhs12191 | mesodermal tumor cell line:HIRS-BM | 0.2 |
| CNhs13359 | Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5) | 0.2 |
| CNhs12317 | parietal lobe, adult, donor10252 | 0.2 |
| CNhs12035 | Osteoblast - differentiated, donor3 | 0.2 |
| CNhs13585 | Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57) | 0.2 |
| CNhs12380 | chorionic membrane cells, donor3 | 0.2 |
| CNhs13621 | mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3 | 0.2 |
| CNhs14585 | Myoblast differentiation to myotubes, day12, control donor3 | 0.2 |